| ANGPT | Angiopoietin |
| ARG1 | Arginase 1 |
| CAFs | Cancer-associated fibroblasts |
| CSC | Cancer stem cell |
| CSF | Colony stimulating factor |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| ECM | Extracellular matrix |
| EGF | Epidermal growth factor |
| EMT | Epithelial-to-mesenchymal transition |
| EPR | Enhanced permeability and retention |
| FAP | Fibroblast activation protein |
| FGF | Fibroblast growth factor |
| FRβ | Targeted-folate-receptor beta |
| GM-CSF | Granulocyte-macrophage colony stimulating factor |
| HGF | Hepatocyte growth factor |
| HIF-1 | Hypoxia-induced factor-1 |
| IL | Interleukin |
| IFN | Interferon |
| iNOS | Inducible nitric oxide synthase |
| MCTS | Multicellular tumor spheroids |
| MDR | Multidrug resistance |
| MDSCs | Myeloid-derived suppressive cells |
| MMPs | Matrix metalloproteinases |
| MT | Malignant transition |
| NSCLC | Non-small cell lung cancer |
| NK | Natural killer |
| NKT | Natural killer T |
| PD-1 | Programmed death 1 receptor |
| PDMS | Polymethylsiloxane |
| PlGF | Placental growth factor |
| PDGF | Platelet-derived growth factor |
| PHD-2 | Prolyl-hydroxylase enzyme-2 |
| TAM | Tumor-associated macrophage |
| TCDEs | Tumor cells derived exosomes |
| TME | Tumor microenvironment |
| TGF | Transforming growth factor |
| TNF | Tumor necrosis factor |
| Treg | Regulatory T cells |
| VEGF | Vascular endothelial growth factor |